
Solvay Sale of Amphoteric Surfactant Business to OpenGate Capital
5th January 2021
Deal Size: Undisclosed
Natrium Capital Limited is pleased to announce it has advised Solvay S.A. (“Solvay”) on the sale of its North American and European amphoteric surfactant business to OpenGate Capital (“OpenGate”). The sale includes the three main production sites supporting the amphoteric product lines located in University Park (Illinois, USA), Genthin (Germany), Halifax (United Kingdom), and a tolling business in Turkey. The agreement also includes tolling and service agreements between Solvay and OpenGate to ensure a seamless transition and minimal customer disruption.
Full Natrium Capital announcementSolvay Press Release
Deal Categories: Chemicals, Personal Care, Specialty/Fine Chemicals